Citigroup’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8
| Closed | -$6 | – | 5044 |
|
|
2023
Q1 | $6 | Hold |
8
| – | – | ﹤0.01% | 4686 |
|
|
2022
Q4 | $7 | Sell |
8
-6,577
| -100% | -$5.76K | ﹤0.01% | 4915 |
|
|
2022
Q3 | $40K | Sell |
6,585
-488
| -7% | -$2.96K | ﹤0.01% | 3779 |
|
|
2022
Q2 | $29K | Buy |
+7,073
| New | +$29K | ﹤0.01% | 4117 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 5622 |
|
|
2021
Q2 | $0 | Sell |
1
-609
| -100% | – | ﹤0.01% | 5721 |
|
|
2021
Q1 | $4K | Sell |
610
-1,160
| -66% | -$7.61K | ﹤0.01% | 5300 |
|
|
2020
Q4 | $8K | Buy |
1,770
+1,328
| +300% | +$6K | ﹤0.01% | 4937 |
|
|
2020
Q3 | $2K | Sell |
442
-804
| -65% | -$3.64K | ﹤0.01% | 4941 |
|
|
2020
Q2 | $36K | Sell |
1,246
-12
| -1% | -$347 | ﹤0.01% | 3925 |
|
|
2020
Q1 | $27K | Buy |
1,258
+370
| +42% | +$7.94K | ﹤0.01% | 4208 |
|
|
2019
Q4 | $18K | Buy |
+888
| New | +$18K | ﹤0.01% | 4533 |
|